Echocardiography plays an important role in the assessment of diastolic function in patients with known or suspected heart failure and patients presenting with dyspnea. Assessing Left Ventricular Diastolic Function is comprised of case-based lectures followed by case studies. The dedicated lectures include questions on the echo parameters used to assess diastolic function and the physiology of diastology. This educational tool also describes how to utilize the ASE and EACVI 2016 guideline on diastology to classify and grade diastolic function, estimate left atrial filling pressure in patients, and evaluate patients with indeterminate diastolic function. You will also learn about the differential diagnosis of patients presenting with dyspnea such as restrictive cardiomyopathy and constrictive pericarditis, as well as the physiology of diastolic function, and the pitfalls in the assessment of diastology.
This educational product is intended for cardiologists, anesthesiologists, cardiac sonographers, fellows, and other medical professionals interested in a comprehensive review of diastology and applying the updated diastology guideline in routine clinical practice.
Authors: Susan A. Mayer, MD, FASE, Chair; Hisham Dokainish, MD, FASE; S. Allen Luis, MD, FRACP, FACC, FASE; Menhel Kinno, MD, MPH; Kameswari Maganti, MD, FACC, FASE; Lena Mathews, MD; Sherif Nagueh, MD, FASE; Sithu Win, MD, MPH.
Release Date: February 28, 2019
CME End Date: February 28, 2022
CME Credit: 8.0
Speaker Disclosure: None
Commercial Support: None
Ultrasound contrast agents, also known as ultrasound enhancing agents, are composed of acoustically active microbubbles. These agents undergo cavitation in an acoustic field, thereby producing strong ultrasound signals that can be detected by unique contrast-specific imaging algorithms available on most ultrasound systems. Ultrasound contrast agents are used to enhance the blood pool, thereby improving patient care by: (1) improving accuracy for left ventricular (LV) volume and function assessment, (2) improving accuracy for detecting regional wall motion at rest and during stress, (3) increasing the ability to detect and characterize thrombi and other masses, and (4) improving accuracy for conditions that influence LV geometry (pseudoaneurysm, non-compaction cardiomyopathy, apical hypertrophic cardiomyopathy).
This educational program provides key information for both early users and established users of ultrasound enhancing agents and is intended to promote the adoption and appropriate use of contrast in echocardiography more broadly. The content of the lectures has been carefully selected by top experts in the field to provide valuable information regarding the contrast agents available, the methods used to detect them, policies and procedures necessary for integration of contrast echocardiography, appropriate indications for contrast using case-based approaches, and advanced uses such as perfusion imaging. The use of physician-sonographer teams in the live program is intended to stress the need for team-based implantation of contrast policies and procedures.
The duration of each of the lectures (20-25 min) has been intentionally designed to provide key information in a succinct fashion. We are confident that this program will be valued for both the quality of its didactic content and the “personal touch” of live webinars that allows individuals to have their questions addressed.
Authors: Jonathan R. Lindner, MD, FASE; Sharon L. Mulvagh, MD, FASE, FRCP(C); Thomas R. Porter, MD, FASE; Howard Leong-Poi, MD, FASE; Margaret Park, BS, ACS, RDCS, RVT, FASE; Rajesh Janardhanan, MD, MRCP, FACC, FASE; G. Monet Strachan, ACS, RDCS, FASE
Release Date: January 18, 2019
CME End Date: January 18, 2022
CME Credit: 6.0
Speaker Disclosure: Jonathan R. Lindner, MD, FASE - Investigator-initiated Grants from GE Healthcare, Lantheus, Pfizer, and Bracco; Sharon L. Mulvagh, MD, FASE, FRCP(C) - GE Healthcare (Research Grants), Lantheus Medical Imaging (Consulting), Bracco Diagnostics (Consulting); Thomas R. Porter, MD, FASE - Bracco Diagnostics (Speakers Bureau), Philips Healthcare (Equipment Support); Howard Leong-Poi, MD, FASE - Lantheus Medical Imaging (Speakers Bureau), Bracco (Clinical Trials); Margaret Park, BS, ACS, RDCS, RVT, FASE - Lantheus Medical Imaging (Speakers Bureau), Lantheus Medical Imaging (Speakers Bureau Advisory Board), Previous faculty and speaker for Northwest Imaging Forums (Sponsored by Bracco); Rajesh Janardhanan, MD, MRCP, FACC, FASE - Lantheus Medial Imaging (Speakers Bureau); G. Monet Strachan, ACS, RDCS, FASE - Lantheus (Speakers Bureau).
Commercial Support: This program was made possible by the funding of an unrestricted educational grant from GE Healthcare, Pharmaceutical Diagnostics.
Proper Echocardiographic Measurements: How and Why is a guideline-based product focused on the methods used to obtain measurements, including explanations describing why such methods are appropriate. This educational tool comprises a combination of didactic lectures and clinical questions. It can be used as a review for experienced sonographers, as well as a training tool for new or early-career sonographers and others who are interested in the practice of cardiovascular ultrasound. Topics include imaging measurements (2D vs. M-mode, LV linear dimensions, basal cardiac measurements, LV volume, LA volume, inferior vena cava, and right ventricle) as well as velocity measurements (spectral Doppler, mitral inflow, mitral annulus, pulmonary vein, mitral stenosis, tricuspid regurgitation, aortic valve, and HOCM).
Three-dimensional (3D) echocardiography has multiple advantages for the visualization of cardiac anatomy, chamber quantification, and guidance of transcatheter interventions.
In this DVD, experts in 3D echocardiography address essential topics in a case-based approach with multiple examples. The DVD begins with history of the technology and moves to the basics of image acquisition and display. Subsequent lectures focus on chamber quantification and valvular heart disease. The use of 3D echocardiography to guide transcatheter interventions is also examined in depth. Finally, a vision for the future of 3D echocardiography, including virtual reality, fusion imaging, and holographic display is presented.
This teaching tool has multiple benefits including the capacity to quickly gain knowledge and improve your understanding of the capabilities of this novel imaging technique, the aptitude to visualize dynamic images in our clinical work, and an understanding of the potential future of 3D echocardiography.
This 3D echocardiography lecture series was created to help instruct and expand your knowledge and confidence of interpretation of this imaging modality. We hope you enjoy this learning experience.
These case-based, educational tools are for anesthesiologists, cardiologists, fellows, surgeons, and other interested individuals currently performing and/or interpreting transesophageal echocardiography (TEE) for intraoperative procedures. Throughout these activities, surgical cases have been used to showcase the value of TEE in the perioperative setting. Topics include, but are not limited to: LV function, RV function, diseases of the aorta, aortic valve and root, LVOT (Including HCM), mitral valve stenosis, mitral valve regurgitation, tricuspid valve, atrial septum, and other intraoperative uses outside of monitoring and emergency diagnosis.
Cardiovascular Point-of-Care Imaging for the Medical Student and Novice User introduces basic cardiac point-of-care ultrasound concepts for all stages of medical school. The curriculum is modular in format, allowing educators and learners to select the components needed to either enhance their existing ultrasound programming, or to use the modules as a starting point to deliver cardiovascular point-of-care education. Modules include anatomy, integration with the physical exam, pathology, 'teach the teacher', and testing themes. The Cardiovascular Point-of-Care Imaging for the Medical Student and Novice User is endorsed by ASE's partners, WINFOCUS and the Canadian Society of Echocardiography.